Keyphrases
Antipsychotics
100%
First-episode Psychosis
93%
Psychiatrists
41%
Schizophrenia Spectrum Disorders
34%
Symptom Severity
34%
Cognitive Subgroups
31%
Daily Functioning
31%
Dopamine D2
31%
Positive Symptoms
31%
Negative Symptoms
31%
Pharmacotherapy
31%
Patient Characteristics
13%
Shared Decision Making
13%
Estrogen
12%
High Dose
12%
Partial Agonist
12%
Relevant Evidence
10%
Daily Dose
10%
Personal Considerations
10%
Remission
10%
Therapeutic Approaches
10%
Specific Patient
10%
Older Men
10%
Mental Health Problems
10%
Personal Experience
10%
Hypersomnia
10%
Dutch Guideline
10%
Symptom Remission
10%
Tiredness
10%
Relapse Risk
10%
Schizophreniform Disorder
10%
Prescribed Dose
6%
Symptomatic Outcome
6%
Explained Variance
6%
Baseline Severity
6%
Hyperprolactinemia
6%
Pharmacokinetics
6%
Deficiency Symptoms
6%
Estrogen Deficiency
6%
Postmenopausal Women
6%
Olanzapine
6%
Menopause
6%
Metabolic Symptoms
6%
Cardiovascular Disease
6%
Clinical Practice
6%
Dopamine Receptor Availability
6%
Pharmacodynamics
6%
Ovulation
6%
Protective Effect
6%
Prescription Guidelines
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
93%
Side Effect
43%
Schizophrenia Spectrum Disorder
31%
Typical Antipsychotic
31%
Pharmacotherapy
31%
Psychosis
31%
Positive Syndrome
31%
Symptom
28%
Remission
20%
Comorbidity
15%
Hypersomnia
10%
Disease
10%
Fatigue
10%
Isoprenaline
10%
Schizophreniform Disorder
10%
Sex Hormone
7%
Tolerability
7%
Dopamine Receptor
7%
Replacement Therapy
7%
Quetiapine
7%
Pharmacokinetics
7%
Drug Absorption
7%
Estrogen Deficiency
7%
Lurasidone
7%
Pharmacodynamics
7%
Hyperprolactinemia
7%
Cardiovascular Disease
7%
Drug Excretion
7%
Olanzapine
7%
Medicine and Dentistry
Drug Therapy
62%
Side Effect
38%
Schizophrenia Spectrum Disorder
31%
Typical Antipsychotic
31%
Symptom
23%
Drug Megadose
15%
Kleine-Levin Syndrome
7%
Fatigue
7%
Personal Experience
7%
Shared Decision Making
7%
Mental Health
7%
Lurasidone
7%
Psychiatrist
7%
Patient Characteristics
7%
Schizophreniform Disorder
7%
Disease
7%
Isoprenaline
7%
Ovulation
7%
Olanzapine
7%
Estrogen Deficiency
7%
Premenopause
7%
Drug Excretion
7%
Pharmacokinetics
7%
Receptor Occupancy
7%
Clinician
7%
Quetiapine
7%
Hormone Determination
7%
Sex Hormone
7%
Dopamine Receptor
7%
Cardiovascular Disease
7%
Drug Absorption
7%
Pregnancy
7%
Drug Metabolism
7%
Pharmacodynamics
7%
Estrogen Therapy
7%
Hyperprolactinemia
7%